Get started
Work

Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer

Year: 2019
Type: article
DOI: 10.1093/annonc/mdz244.007
Authors: D.M. Hyman, C.M. van Tilburg, C.M. Albert, D.S.W. Tan, B. Geoerger, A.F. Farago, T.W. Laetsch, S. Kummar, F. Doz, U.N. Lassen, S.G. DuBois, R. McDermott, L. Mascarenhas, J.D. Berlin, E.R. Rudzinski, M.C. Cox, S. Nanda, B.H. Childs, A. Drilon, D.S. Hong
Institutions: Memorial Sloan Kettering Cancer Center, German Cancer Research Center, University Hospital Heidelberg, Hopp Children's Cancer Center Heidelberg, Seattle Children's Hospital, University of Washington, National Cancer Centre Singapore, Université Paris-Sud, Université Paris-Saclay, Institut Gustave Roussy, Massachusetts General Hospital, The University of Texas Southwestern Medical Center, Stanford Medicine, Stanford University, Institut Curie, Rigshospitalet, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Cancer Trials Ireland, St. Vincent's University Hospital, University of Southern California, Vanderbilt University, Bayer (United States), The University of Texas MD Anderson Cancer Center
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2978070200
FWCI: 3.152
Cites:
Cited by: 16
Related to: 10